Introduction: In May 2020, the World Health Organization recognized olfactory dysfunction as a COVID-19 symptom. The presence of hyposmia/anosmia may be a marker of good prognosis in COVID-19.
Objective: To associate the presence of olfaction disorder to the clinical condition severity in patients with COVID-19.
Purpose: To compare two rat ovary cryopreservation techniques (vitrification vs. slow freezing) and two postmenopausal stages (early vs. late) with regard to graft take.
View Article and Find Full Text PDF